infected host, then injects it into the bloodstream of the new host with a subsequent bite.
In many cases, the organism also replicates in the vector, increasing its chances of infect-
ing the next human host successfully.
The environmental engineer or scientist may especially need to be aware of diseases
transmitted by mosquitoes. Certain types of water projects (dams, canals) may increase or
decrease the prevalence of the waterbodies in which various types of mos quito larvae
develop. Also, the use of pesticides to control mosquitoes has both provided important
public health benefits from reduced disease transmission and caused serious environmen-
tal impacts on nontarget species, including humans.
12.5.1 Malaria
Malaria is endemic to nearly 100 countries, and more than 40% of the world’s population
is at risk. This is the fourth most common infectious disease, with perhaps 300 million
cases and 2 million annual fatalities. Many of the victims are children living in Africa
south of the Sahara Desert who do not have access to prophylactic antimalarial drugs.
Although malaria was once an endemic problem in the southeastern United Stat es, the
current U.S. incidence (1000 infections and one death per year) is largely associated
with travel to infected areas.
Malaria has been recognized for centuries, being attributed originally to the dank,
miasmic atmosphere associated with humid swampy areas. In fact, the name given to
this disease, mal aria (literally, ‘‘bad air’’), reflects this early hypothesis. The true culprit,
however, is a sporozoan parasite, Plasmodium. The vectors are female mosquitoes of the
genus Anopheles.
There are four species of Plasmodium linked with malaria; some lie dormant for sev-
eral years, and others can be acutely lethal. Upon infection the protozoan proceeds to the
liver, where it reproduces and infects red blood cells, eventually interfering with the
body’s ability to transfer oxygen. Symptoms, including fatigue, anemia, fevers or chills,
and nausea, may be similar to those of flu or food pois oning, and in many instances they
are mistakenly overlooked by travelers as jet lag. Plasmodium vivax can linger within a
victim’s liver for many years, causing recurring periods of incapacitating fatigue. Similar
chronic problems can be caused by P. ovale or P. malariae. However, an infection by P.
falciparum can be fatal within a single day following the initial onset of symptoms.
Drugs to counteract malaria were originally derived from a chemical known as quinine,
extracted from the bark of trees found in the Amazon rain forest. For many years, the
quinine derivative chloroquine provided a high degree of protection, but in recent decades
its effectiveness has been compromised by the evolution of drug-resistant Plasmodium
strains. A new generation of improved drugs has been devised, but resistance to these
has also started to appear. The best control in many places, including the United States,
has come from eradication of the insect vector, preventing transmission.
12.5.2 Trypanosomiasis (African Sleep ing Sickness)
African sleeping sickness is a chronic and often fatal disease caused by the flagellated
protozoans Trypanosoma gamb iense (central Africa) and T. rhodesiense (eastern Africa).
It is spread by blood-feeding tsetse flies and infects a variety of animals. The ‘‘sleep’’ is
really a coma resulting from invasion of the brain. South American sleeping sickness, or
Chaga’s disease, is caused by T. cruzi and is spread by biting triatomid bugs.
372 EFFECT OF MICROBES ON HUMAN HEALTH